Sandoz signs non-binding term sheet with Evotec SE to acquire its Just-Evotec Biologics in-house development and manufacturing capabilities in Toulouse, France

Notified -

Sandoz receives European Commission approval for Wyost® and Jubbonti®, the first and only biosimilars of denosumab in Europe

Sandoz reports first quarter 2024 sales

Shareholders approve all resolutions proposed by Board of Directors at Annual General Meeting of Sandoz Group AG

Sandoz US subsidiaries resolve generic drug antitrust class action litigation with direct purchaser class plaintiffs

Sandoz announces changes in the Board of Directors

United Language Group Receives John Deere Achieving

ULG Continues to Provide Innovative Language Solutions for John Deere’s Growing Global Communication Needs...